Xun Qi (Qi Xun)

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 11

Top Topics

Dendritic Cells

Patient Reported

Ejection Fraction

Top Venues

Journal of viral hepatitis

Canadian journal of gastroenterology & hepatology

BioMed research international

This page only lists publications with an associated author ORCID identifier.

Publications

Xiongyue Cao, Qiankun Hu, Wei Xu, Qiang Li, Ji-Ming Zhang, Liang Chen, Yuxian Huang, Xun Qi
Kinetics changes in total cholesterol predict HBeAg seroconversion in chronic hepatitis B patients treated with pegylated interferon-alfa. Journal of viral hepatitis 30 (4) (2023)
Xiongyue Cao, Qiankun Hu, Wei Xu, Qiang Li, Ji-Ming Zhang, Liang Chen, Yuxian Huang, Xun Qi
Kinetics changes in total cholesterol predict HBeAg seroconversion in chronic hepatitis B patients treated with pegylated interferon-alfa. Journal of viral hepatitis 30 (4) (2023)
Xiongyue Cao, Qiankun Hu, Wei Xu, Qiang Li, Ji-Ming Zhang, Liang Chen, Yuxian Huang, Xun Qi
Kinetics changes in total cholesterol predict HBeAg seroconversion in chronic hepatitis B patients treated with pegylated interferon-alfa. Journal of viral hepatitis 30 (4) (2023)
Yiran Xie, Haoxiang Zhu, Yifei Guo, Zhenxuan Ma, Xun Qi, Feifei Yang, Ri-Cheng Mao, Ji-Ming Zhang
Reduction of Hepatitis B Surface Antigen May Be More Significant in PEGylated Interferon-Alpha Therapy Combined with Nucleotide Analogues than Combined with Nucleoside Analogues in Chronic Hepatitis B Patients: A Propensity Score Matching Study. Canadian journal of gastroenterology & hepatology 2022 (2022)
Xiongyue Cao, Qiankun Hu, Wei Xu, Qiang Li, Ji-Ming Zhang, Liang Chen, Yuxian Huang, Xun Qi
Kinetics changes in total cholesterol predict HBeAg seroconversion in chronic hepatitis B patients treated with pegylated interferon-alfa. Journal of viral hepatitis (2022)
Xiongyue Cao, Qiankun Hu, Wei Xu, Qiang Li, Ji-Ming Zhang, Liang Chen, Yuxian Huang, Xun Qi
Kinetics changes in total cholesterol predict HBeAg seroconversion in chronic hepatitis B patients treated with pegylated interferon-alfa. Journal of viral hepatitis (2022)
Yiran Xie, Haoxiang Zhu, Yifei Guo, Zhenxuan Ma, Xun Qi, Feifei Yang, Ri-Cheng Mao, Ji-Ming Zhang
Reduction of Hepatitis B Surface Antigen May Be More Significant in PEGylated Interferon-Alpha Therapy Combined with Nucleotide Analogues than Combined with Nucleoside Analogues in Chronic Hepatitis B Patients: A Propensity Score Matching Study. Canadian journal of gastroenterology & hepatology 2022 (2022)
Yiran Xie, Haoxiang Zhu, Yifei Guo, Zhenxuan Ma, Xun Qi, Feifei Yang, Ri-Cheng Mao, Ji-Ming Zhang
Reduction of Hepatitis B Surface Antigen May Be More Significant in PEGylated Interferon-Alpha Therapy Combined with Nucleotide Analogues than Combined with Nucleoside Analogues in Chronic Hepatitis B Patients: A Propensity Score Matching Study. Canadian journal of gastroenterology & hepatology 2022 (2022)
Yiran Xie, Haoxiang Zhu, Yifei Guo, Zhenxuan Ma, Xun Qi, Feifei Yang, Ri-Cheng Mao, Ji-Ming Zhang
Reduction of Hepatitis B Surface Antigen May Be More Significant in PEGylated Interferon-Alpha Therapy Combined with Nucleotide Analogues than Combined with Nucleoside Analogues in Chronic Hepatitis B Patients: A Propensity Score Matching Study. Canadian journal of gastroenterology & hepatology 2022 (2022)
Hong-Ying Guo, Beidi Zhu, Shu Li, Jing Li, Zhiqing Shen, Yijuan Zheng, Weidong Zhao, Dan Tan, Jingwen Wu, Xueyun Zhang, Qirong Jiang, Xun Qi, Richeng Mao, Xue-Ping Yu, Zhijun Su, Ji-Ming Zhang
Development and Validation of a Novel Model to Predict Liver Histopathology in Patients with Chronic Hepatitis B. BioMed research international 2019 (2019)
Xiaojing Ren, Yuanyuan Ji, Xuhua Jiang, Xun Qi
Downregulation of CYP2A6 and CYP2C8 in Tumor Tissues Is Linked to Worse Overall Survival and Recurrence-Free Survival from Hepatocellular Carcinoma. BioMed research international 2018 (2018)